SCHEMBL5334574

SCHEMBL5334574

CCCOC(=O)C1=C(C)NC2=C(C(=O)C(C(=O)OC)C(C)C2)C1c1cccs1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.68
ALDH1A1 P00352 9/20 0.68
CASP1 P29466 7/20 0.68
GAA P10253 5/20 0.68
MAPT P10636 5/20 0.67
CASP7 P55210 3/20 0.67
HTT P42858 1/20 0.67
HSD17B10 Q99714 7/20 0.64
ALOX15 P16050 3/20 0.64
LMNA P02545 2/20 0.58
POLB P06746 2/20 0.58
AGTR1 P30556 1/20 0.58
USP2 O75604 3/20 0.57
TP53 P04637 2/20 0.57
HPGD P15428 4/20 0.54
TSHR P16473 2/20 0.54
ADORA2B P29275 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5334014 0.94 KDM4E (0.66) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5334058 0.91 KDM4E (0.57) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5335039 0.90 KDM4E (0.56) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5335812 0.86 ALDH1A1 (0.71) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5328258 0.84 ALDH1A1 (0.68) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5339867 0.82 ALDH1A1 (0.68) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5337726 0.82 ALDH1A1 (0.68) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5482759 0.82 ALDH1A1 (0.81) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5336757 0.82 ALDH1A1 (0.81) KDM4EALDH1A1CASP1GAAMAPT
SCHEMBL5334382 0.82 ALDH1A1 (0.81) KDM4EALDH1A1CASP1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
WO-2007051062-A2 SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112015-A1 Substituted dihydropyridines and methods of use C3AR1, C5AR1, C5AR2 KDM4E 4033/4885ALDH1A1 1488/4885CASP1 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.